The latest price list of erdafitinib in 2024 and price comparison of different versions

Erdafitinib is a targeted therapy drug mainly used to treat urothelial cancer driven by FGFR mutations. The drug interferes with the proliferation and spread of tumor cells by inhibiting the fibroblast growth factor receptor (FGFR), and is especially useful for patients whose disease has progressed despite chemotherapy. Although erdafitinib has been approved in many countries, many patients face financial pressure when purchasing it due to its high price and lack of medical insurance coverage.

In China, erdafitinib is already on the market, but it is not currently covered by medical insurance, so patients need to purchase it at their own expense. Since the drug has not been on the market for a long time and is mainly supplied by imported drugs, direct purchase of erdafitinib may encounter some difficulties. In order to obtain the drug, some patients choose to purchase it through overseas channels such as Hong Kong. The original drug of erdafitinib on the Hong Kong market is relatively expensive. The price of a box (120tablets) is usually around RMB 20,000. Patients can purchase it through Hong Kong pharmacies. However, due to the higher price, this is still a significant expense for some patients.

Compared with the original drug, the generic drug of erdafitinib on the foreign market is much cheaper. The main versions of generic drugs include Laos version and Bangladesh Yaopin International version. The prices of these generic drugs usually range from a few hundred yuan to more than 2,000 yuan. Although they are cheap, the ingredients of these generic drugs are basically the same as those of the original drugs, and their efficacy and safety are usually guaranteed, so they have become the choice of many patients. Especially in China, generic drugs have become a viable option for patients with limited financial conditions.

To sum up, the price of erdafitinib varies greatly depending on the version and purchase channel. Original drugs are relatively expensive and are mainly purchased from imported pharmacies, while generic drugs have become an alternative choice for some patients due to their lower prices. When choosing purchasing channels, patients should make comprehensive considerations based on their own financial situation, drug quality assurance and legality.